Q3 FY2024 · Press release
2 pages
Read Halozyme Therapeutics, Inc.'s results firsthand
Preview this press release
Create a free account to start reading
Full documents are included with Professional
Halozyme Therapeutics, Inc.
130.34
USD
+1.72
(+1.34%)
